Værdien af MRI Til Staging af c.Ovarii-et Prospektivt Studie
N/A
N/A
Female
Ovarian Cancer
Trial Information
Værdien af MRI Til Staging af c.Ovarii-et Prospektivt Studie
Staging of ovarian cancer can best be performed with CT or MRI compared to ultrasound.
Studies have shown an increase in pos. predictive value by adding contrast i.v. to the
MR-examination protocol. We compare staging of ovarian cancer by 1.MRI without contrast
(standard method) to 2.MRI with contrast agent i.v. (new method)in the same patient. Golden
standard are findings at operation.
Inclusion Criteria:
- suspicion of ovarian cancer
Exclusion Criteria:
- recurrence of disease
- contraindication to MRI, contrast agent
- inoperable patients for other reasons
Type of Study:
Observational
Study Design:
Observational Model: Case Control, Primary Purpose: Screening, Time Perspective: Longitudinal, Time Perspective: Prospective
Principal Investigator
Liselotte Ibsen, doc
Investigator Role:
Principal Investigator
Investigator Affiliation:
Aarhus University Hospital, BDA, Skejby
Authority:
Denmark: Ethics Committee
Study ID:
MR-Center-001
NCT ID:
NCT00463996
Start Date:
April 2007
Completion Date:
April 2008
Related Keywords:
- Ovarian Cancer
- Ovarian cancer
- MRI
- Contrast agent
- Ovarian Neoplasms
Name | Location |
|---|
